{
    "title": "Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12112147/Pfizers-diabetes-drug-results-similar-weight-loss-levels-Novos-Ozempic.html",
    "date": "2023-05-22",
    "keywords": [
        "loss",
        "midstage",
        "drug",
        "study",
        "pfizer",
        "treatment",
        "weight",
        "dose",
        "danuglipron",
        "ozempic",
        "wegovy",
        "news",
        "time",
        "investor",
        "interest",
        "weightloss",
        "market",
        "end",
        "decade",
        "day",
        "blood",
        "sugar",
        "body",
        "year",
        "peer",
        "placebo",
        "jama",
        "network",
        "monday",
        "magnitude",
        "obesity",
        "class",
        "gut",
        "hormone",
        "glucagonlike",
        "peptide1",
        "glp1",
        "appetite",
        "lotiglipron",
        "latestage",
        "development",
        "company",
        "therapy",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "shilpi",
        "majumdar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}